The Democratic Republic of Congo (DRC) launched the R21 malaria vaccine as part of its national immunisation programme, with the aim of significantly reducing the impact of malaria on young children. The first phase of the vaccine launch commenced in Kongo Central province with the administration of 173,375 doses to 31 health zones, following the provision of 693,500 doses by the WHO. Support from WHO, UNICEF, Gavi, the Clinton Health Access Initiative, PATH, Breakthrough Action and the local NGO SANRU is ensuring effective distribution of the vaccine. Roger Kamba, Minister of Health, stressed the importance of integrating the malaria vaccine into the country’s existing control measures, which include preventive treatment for vulnerable populations and chemoprevention of seasonal malaria. With the introduction of this malaria vaccine, the DRC joins 14 other African countries offering this crucial protection. The vaccine launch is part of the DRC’s National Strategic Plan 2024-2028, which aims to protect 80% of at-risk populations by combining various interventions against malaria. These include increased distribution of insecticide-treated nets, better vector control, rapid diagnostics and greater community involvement, supported by multi-sectoral collaboration between the health, education and environment sectors.
October 31, 2024
